LMD-10. The role of immune checkpoint inhibitors in leptomeningeal disease: a systematic review
Paolo Palmisciano(University of California, Davis), Tarek Y. El Ahmadieh(Neurological Surgery), Kenny Yu(Memorial Sloan Kettering Cancer Center), Ali S. Haider(Bryan College), Chibawanye Ene(The University of Texas MD Anderson Cancer Center), Chibueze D. Nwagwu(Emory University), Navraj S. Sagoo(The University of Texas Medical Branch at Galveston), Aaron Cohen‐Gadol(University of Southern California), Barbara O’Brien(The University of Texas MD Anderson Cancer Center), Waseem Wahood(University of Miami)
Cited by 0
Related Papers
Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity
|Nature Cancer|2021|334
Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance
|Journal of neurosurgery|2015|206